ProSomnus® Debuts as Publicly Traded Company Focused on Disrupting Obstructive Sleep Apnea Treatment Market with Patient-preferred Precision Oral Appliance Therapy Devices Dec 6, 2022 05:55PM
ProSomnus® Debuts as Publicly Traded Company Focused on Disrupting Obstructive Sleep Apnea Treatment Market with Patient-preferred Precision Oral Appliance Therapy Devices Dec 6, 2022 05:55PM
ProSomnus®, Leader in Patient-Preferred Sleep Apnea Therapy, to be Listed on Nasdaq Through Business Combination with Lakeshore Acquisition I Corp. May 10, 2022 08:00AM
Lakeshore Acquisition I Corp. (LAAA) Prices 5M Unit IPO at $10/Unit Jun 11, 2021 06:29AM